Avapritinib in advanced PDGFRA D842V-mutant gastrointestinal stromal tumour (NAVIGATOR): a multicentre, open-label, phase 1 trial - Heinrich, M C; Jones, R L; von Mehren, M (Lancet Oncol, 2020)